Although broad generalisations can be drawn when comparing the biophysical impact of NaV1.7 variants with clinical phenotype (for instance that inherited erythromelalgia is associated with enhanced channel activation and PEPD with impaired channel inactivation), we still have an incomplete understanding of how channel dysfunction causes specific pain phenotypes. Here, SCN9A is linked to erythromelalgia.